Faculty Information - NABEKA Hiroaki

Educational Background

Work experience /Academic appointments

Publications

（Last updated : 2024-02-08 14:44:23）

NABEKA Hiroaki
Department Matsuyama University School of Clinical Pharmacy, College of Pharmaceutical Sciences

Position Professor

Educational Background

2006/04～2010/03

〔Doctoral course〕, Graduate School, Division of Medical Sciences, Ehime University, Completed,

Work experience /Academic appointments

2010/04～2018/03

Assistant Professor

Publications

1.	2023/12	Article	Neurotoxic stimulation alters prosaposin levels in the salivary systems of rats (Collaboration)
2.	2023/09	Article	Tracking of Prosaposin, a Saposin Precursor, in Rat Testis (Collaboration)
3.	2023/04	Article	Administration of prosaposin-derived neurotrophic factor to neural tube defects facilitates regeneration and restores neurological functions (Collaboration)
4.	2022/08	Article	A comprehensive design for prevention and management of COVID-19 in a tertiary medical institution in Bangladesh (Collaboration)
5.	2021/08	Article	The expression of prosaposin and its receptors, GRP37 and GPR37L1, are increased in the developing dorsal root ganglion (Collaboration)
6.	2021/06	Article	Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA (Collaboration)
7.	2021/02	Article	Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity (Single)
8.	2021	Article	Postmortem interval estimation by evaluating saposin D levels and morphological alterations in hippocampal neurons (Collaboration)
9.	2020/12	Article	Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19. (Collaboration)
10.	2020/12	Article	Prosaposin and Its Receptors, GRP37 and GPR37L1, Protects Neurons Against In Vivo Neuropathological Disorders (Collaboration)
11.	2020/12	Article	Reply to “Ivermectin Treatment May Improve the Prognosis of Patients with COVID-19” (Collaboration)
12.	2020/12	Article	Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers. (Collaboration)
13.	2020/11	Article	Expression of the G protein-coupled receptor (GPR) 37 and GPR37L1 in the mouse digestive system. (Collaboration)
14.	2020/11	Article	Prosaposin in the rat oviductal epithelial cells. (Collaboration)
15.	2020/01	Article	Age- and sex-associated changes in prosaposin and its receptors in the lacrimal glands of rats. (Collaboration)
16.	2020	Article	Prosaposin and its receptors GRP37 and GPR37L1 show increased immunoreactivity in the facial nucleus following facial nerve transection. (Collaboration)
17.	2020	Article	Suppression of GABAergic transmission in the spinal dorsal horn induces pain-related behaviour in a chicken model of spina bifida. (Collaboration)
18.	2018/08	Article	Prosaposin and its receptors are differentially expressed in the salivary glands of male and female rats. (Collaboration)
19.	2017/12	Article	Early neonatal loss of inhibitory synaptic input to the spinal motor neurons confers spina bifida-like leg dysfunction in a chicken model. (Collaboration)
20.	2017/12	Article	Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity. (Collaboration)
21.	2017/06	Article	Expression of prosaposin and its receptors in the rat cerebellum after kainic acid injection. (Collaboration)
22.	2016/06	Article	An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice. (Collaboration)
23.	2015	Article	A prosaposin-derived Peptide alleviates kainic Acid-induced brain injury. (Collaboration)
24.	2013	Book	Neural Tube Defects: Prevalence, Pathogenesis and Prevention (Collaboration)
Display 5 items
Display all(24)